Insight Wealth Strategies, LLC Vericel Corp Transaction History

Insight Wealth Strategies, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 31, 2020	SELL	$8.5 - $15.82 $85,119 - $158,421	-10,014 Closed	0 $0
Q1 2020 Apr 21, 2020	SELL	$7.25 - $19.22 $188,275 - $499,124	-25,969 Reduced 72.17%	10,014 $92,000
Q4 2019 Feb 21, 2020	SELL	$13.77 - $19.2 $9,308 - $12,979	-676 Reduced 1.84%	35,983 $626,000
Q3 2019 Nov 06, 2019	BUY	$14.93 - $19.83 $345,898 - $459,421	23,168 Added 171.73%	36,659 $555,000
Q2 2019 Aug 06, 2019	BUY	$15.01 - $18.89 $11,377 - $14,318	758 Added 5.95%	13,491 $255,000
Q1 2019 Apr 24, 2019	SELL	$16.23 - $20.29 $2,742 - $3,429	-169 Reduced 1.31%	12,733 $223,000
Q4 2018 Feb 12, 2019	BUY	$10.77 - $18.44 $138,954 - $237,912	12,902 New	12,902 $224,000

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.48B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Insight Wealth Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Insight Wealth Strategies, LLC with notifications on news.